Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D02YXP
|
||||
| Former ID |
DIB021132
|
||||
| Drug Name |
UNC1999
|
||||
| Synonyms |
UNC 1999; UNC-1999
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [532322] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C33H43N7O2
|
||||
| InChI |
InChI=1S/C33H43N7O2/c1-7-8-24-15-23(6)37-33(42)28(24)19-35-32(41)27-16-26(17-30-29(27)20-36-40(30)22(4)5)25-9-10-31(34-18-25)39-13-11-38(12-14-39)21(2)3/h9-10,15-18,20-22H,7-8,11-14,19H2,1-6H3,(H,35,41)(H,37,42)
|
||||
| InChIKey |
DPJNKUOXBZSZAI-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID | |||||
| Target and Pathway | |||||
| Target(s) | Enhancer of zeste homolog 2 | Target Info | Inhibitor | [532322] | |
| KEGG Pathway | MicroRNAs in cancer | ||||
| NetPath Pathway | IL2 Signaling Pathway | ||||
| WikiPathways | Interactome of polycomb repressive complex 2 (PRC2) | ||||
| Endoderm Differentiation | |||||
| Integrated Pancreatic Cancer Pathway | |||||
| Histone Modifications | |||||
| Cell Differentiation - meta | |||||
| miRs in Muscle Cell Differentiation | |||||
| miR-targeted genes in muscle cell - TarBase | |||||
| miR-targeted genes in lymphocytes - TarBase | |||||
| miR-targeted genes in epithelium - TarBase | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.